1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1.Drivers
3.2.2.Restraints
3.2.3.Opportunities
3.2.4.Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for France Neuropathic Pain Market
3.5. IGR-Growth Matrix Analysis
3.6. Competitive Landscape in France Neuropathic Pain Market
4. France Neuropathic Pain Market by
Type
4.1. Phantom Limb Pain
4.2. Trigeminal Neuralgia
4.3. Post Herpetic Neuralgia
4.4. Post-traumatic Neuropathy
5. France Neuropathic Pain Market by
Indication
5.1. Spinal Stenosis
5.2. Diabetic Neuropathy
6. France Neuropathic Pain Market by
Diagnosis
6.1. Imaging Physical
Examination
6.1.1. Electromyography
6.1.2. MRI
6.1.3. CT
6.2. Blood Tests
7. France Neuropathic Pain Market by
Treatment
7.1. Medication Type
7.2. NSAIDs Type
7.2.1. Naproxen
7.2.2. Ibuprofen
7.2.3. Others
7.3. Antidepressant Drugs Type
7.3.1. Tricyclic Antidepressants
7.3.2. Serotonin Noradrenaline
7.4. Multimodal Therapy
8. France Neuropathic Pain Market by
Distribution Channel
8.1. Retail Pharmacies and Drug Stores
8.2. Online Pharmacies
9. France Neuropathic Pain Market by
End User
9.1.
Hospitals
9.2.
Clinics
10.1.
Company 1
10.2.
Company 2
10.3.
Company 3
10.4.
Company 4
10.5. Company 5
1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1.Drivers
3.2.2.Restraints
3.2.3.Opportunities
3.2.4.Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for France Neuropathic Pain Market
3.5. IGR-Growth Matrix Analysis
3.6. Competitive Landscape in France Neuropathic Pain Market
4. France Neuropathic Pain Market by
Type
4.1. Phantom Limb Pain
4.2. Trigeminal Neuralgia
4.3. Post Herpetic Neuralgia
4.4. Post-traumatic Neuropathy
5. France Neuropathic Pain Market by
Indication
5.1. Spinal Stenosis
5.2. Diabetic Neuropathy
6. France Neuropathic Pain Market by
Diagnosis
6.1. Imaging Physical
Examination
6.1.1. Electromyography
6.1.2. MRI
6.1.3. CT
6.2. Blood Tests
7. France Neuropathic Pain Market by
Treatment
7.1. Medication Type
7.2. NSAIDs Type
7.2.1. Naproxen
7.2.2. Ibuprofen
7.2.3. Others
7.3. Antidepressant Drugs Type
7.3.1. Tricyclic Antidepressants
7.3.2. Serotonin Noradrenaline
7.4. Multimodal Therapy
8. France Neuropathic Pain Market by
Distribution Channel
8.1. Retail Pharmacies and Drug Stores
8.2. Online Pharmacies
9. France Neuropathic Pain Market by
End User
9.1.
Hospitals
9.2.
Clinics
10.1.
Company 1
10.2.
Company 2
10.3.
Company 3
10.4.
Company 4
10.5. Company 5